ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.

Journal of Korean medical science

Volumn 17, Issue 5, 2002, Pages 621-624

  Choi, Chul Won ^a   Paek, Chang Won ^a   Seo, Jae Hong ^a   Kim, Byung Soo ^a   Shin, Sang Won ^a   Kim, Yeul Hong ^a   Kim, Jun Suk ^a  

^a Korea University Ansan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; ESAP PROTOCOL; ETOPOSIDE; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; DISEASE FREE SURVIVAL; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; NONHODGKIN LYMPHOMA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SALVAGE THERAPY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CISPLATIN; CYTARABINE; DISEASE-FREE SURVIVAL; DRUG TOLERANCE; ETOPOSIDE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 1842869221     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2002.17.5.621     Document Type: Article

References (0)